Polydex Pharmaceuticals Limited - Current Ratio

The Current Ratio as of June 2026 (TTM) for Polydex Pharmaceuticals Limited (POLXF) is 1.26

According to Polydex Pharmaceuticals Limited’s latest financial reports and current stock price. The company's current Current Ratio is 1.26. This represents a change of -30.84% compared to the average of 1.82 of the last 4 quarters.

Polydex Pharmaceuticals Limited (POLXF) Historical Current Ratio (quarterly & annually)

How has POLXF Current Ratio performed in the past?

The mean historical Current Ratio of Polydex Pharmaceuticals Limited over the last ten years is 2.47. The current 1.26 Current Ratio has changed 4.99% with respect to the historical average. Over the past ten years (40 quarters), POLXF's Current Ratio was at its highest in in the April 2004 quarter at 4.72. The Current Ratio was at its lowest in in the January 2010 quarter at 1.26.

Polydex Pharmaceuticals Limited (POLXF) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Polydex Pharmaceuticals Limited Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Polydex Pharmaceuticals Limited (POLXF) Average Current Ratio

How has POLXF Current Ratio performed in the past?

The current Current Ratio of Polydex Pharmaceuticals Limited (POLXF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Polydex Pharmaceuticals Limited (POLXF) Current Ratio vs. Peers

How is POLXF’s Current Ratio compared to its peers?

Polydex Pharmaceuticals Limited’s Current Ratio is greater than Immune Therapeutics, Inc. (0.01), greater than Tetra Bio-Pharma Inc. (0.81), less than Forward Pharma A/S (117.44), less than Bionomics Limited (14.31), greater than Carebook Technologies Inc. (0.18), greater than Tryp Therapeutics Inc. (0.24), greater than SQI Diagnostics Inc. (0.31), greater than CloudMD Software & Services Inc. (0.83), less than BerGenBio ASA (4.39), greater than Intellipharmaceutics International Inc. (0.04),

Build a custom stock screener for Polydex Pharmaceuticals Limited (POLXF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Polydex Pharmaceuticals Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Polydex Pharmaceuticals Limited (POLXF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Polydex Pharmaceuticals Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.